eli lilly retatrutide phase 3 trial produces up to 30.3% weight loss in Eli Lilly reports positive Phase

Those who stop exercising are also at risk of regaining lost weight

A recent review concludes that ghrelin and GLP-1 also show opposing effects on food reward-associated behaviors in rodent and humans (Decarie-Spain & Kanoski, 2021)

The thigh is one of the three recommended injection sitesalong with the abdomen and upper armbecause it offers good accessibility and a thick layer of subcutaneous tissue that absorbs medication reliably

The objective of this review is to summarize the mechanism of action of incretin receptor agonists, their effects in the gastrointestinal tract, and implications in clinical practice, particularly in the practice of gastroenterology, endoscopy, and surgery.

While California, New Hampshire, Pennsylvania, and South Carolina stopped covering adult GLP-1 prescriptions for obesity on Jan